Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven N Hochwald

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|December 19, 2013
Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survivalHye Seung Lee, Min Chen, Ji Hun Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanomaGeorgia M Beasley, Jonathan C Riboh, Christina K Augustine, et al.
Annals of Surgical Oncology|December 7, 2011
A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremitiesChristy Y Chai, Jeremiah L Deneve, Georgia M Beasley, et al.
JAMA Surgery|April 23, 2015
Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal AdenocarcinomaMoshim Kukar, Raed M Alnaji, Feraas Jabi, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growthDeniz A Ucar, Elena Kurenova, Timothy J Garrett, et al.
Translational Lung Cancer Research|September 27, 2019
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trialsYangyang Xu, Bing Wan, Xi Chen, et al.
Molecular Cancer Therapeutics|December 29, 2011
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancerMin Chen, Daniel Shabashvili, Akbar Nawab, et al.
Journal of the American College of Surgeons|April 6, 2011
Shave biopsy is a safe and accurate method for the initial evaluation of melanomaJonathan S Zager, Steven N Hochwald, Suroosh S Marzban, et al.
Cancers|September 28, 2021
Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer CenterShruti G Dighe, Li Yan, Sarbajit Mukherjee, et al.
Annals of Surgical Oncology|June 23, 2009
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysisAlfredo A Santillan, Keith A Delman, Georgia M Beasley, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|December 19, 2013
Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survivalHye Seung Lee, Min Chen, Ji Hun Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanomaGeorgia M Beasley, Jonathan C Riboh, Christina K Augustine, et al.
Annals of Surgical Oncology|December 7, 2011
A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremitiesChristy Y Chai, Jeremiah L Deneve, Georgia M Beasley, et al.
JAMA Surgery|April 23, 2015
Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal AdenocarcinomaMoshim Kukar, Raed M Alnaji, Feraas Jabi, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growthDeniz A Ucar, Elena Kurenova, Timothy J Garrett, et al.
Translational Lung Cancer Research|September 27, 2019
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trialsYangyang Xu, Bing Wan, Xi Chen, et al.
Molecular Cancer Therapeutics|December 29, 2011
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancerMin Chen, Daniel Shabashvili, Akbar Nawab, et al.
Journal of the American College of Surgeons|April 6, 2011
Shave biopsy is a safe and accurate method for the initial evaluation of melanomaJonathan S Zager, Steven N Hochwald, Suroosh S Marzban, et al.
Cancers|September 28, 2021
Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer CenterShruti G Dighe, Li Yan, Sarbajit Mukherjee, et al.
Annals of Surgical Oncology|June 23, 2009
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysisAlfredo A Santillan, Keith A Delman, Georgia M Beasley, et al.
Pageof 15